Race-based medicine in the US, which has unjustly contributed to racial inequities in clinical care and health outcomes, has reinforced well-documented mistrust toward the health care enterprise.1 The urgency of abolishing race-based medical practices, including the use of algorithms informing risk stratification, diagnosis, and treatment approaches, has fueled national efforts to identify and reform these practices.2 The recent US Organ Procurement and Transplantation Network (OPTN) decision to modify kidney transplant wait times for Black individuals affected by race-based kidney function estimating equations provides an exemplar of how a focus on justice, reform, and repair can advance our efforts to pursue equity.
Download PDF of full article here>
Full article here>
Video - You may be interested in viewing the IOMC video " Systemic Issues Impacting Kidney Disease and Equity" here.
###
